发明名称 |
Stable aqueous formulations of adenovirus vectors |
摘要 |
The present invention is based on the surprising discovery that the inclusion of an anionic polymer in the adenovirus formulation enhances long-term stability of the vector composition. An aqueous formulation comprising an adenovirus vector and at least one anionic polymer is provided, together with methods of the preparation of a storage stable adenovirus aqueous formulation. |
申请公布号 |
US9254332(B2) |
申请公布日期 |
2016.02.09 |
申请号 |
US201414208919 |
申请日期 |
2014.03.13 |
申请人 |
Arecor Limited |
发明人 |
Jezek Jan;Buckler Angela |
分类号 |
A61K47/38;A61K39/00;C12N15/86;A61K47/36;C12N7/00;C07K14/005;A61K9/00;A61K39/235;A61K48/00 |
主分类号 |
A61K47/38 |
代理机构 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
代理人 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
主权项 |
1. An aqueous formulation comprising an adenovirus vector and a dextran sulfate or salt form thereof at a concentration ranging from about 0.5 mg/mL to about 10 mg/mL. |
地址 |
Cambridge GB |